Stock Market Watch

NASDAQ Stocks to Watch for Monday: QTWW, VALV, CLWR, ASTX, and CIGX

by ·


Quantum Fuel Systems Technologies (NASDAQ:QTWW) traded as high as $1.12 during today’s trading session and closed up at the high of the day for a gain of 2.75% from yesterday’s close… QTWW shares have traded as high as $7.51 over the past 52 weeks, which is 85% off that high at last traded stock price. Get my next ALERT 100% FREE

 

Quantum Fuel Systems Technologies Worldwide, a fully integrated alternative energy company, is a leader in the development and production of advanced propulsion systems, energy storage technologies, and alternative fuel vehicles. Quantum’s wholly owned subsidiary, Schneider Power Inc., and affiliate Asola Advanced and Automotive Solar Systems GmbH complement Quantum’s emerging renewable energy presence through the development and ownership of wind and solar farms, and manufacture of high efficiency solar modules.


Shengkai Innovations, Inc. (NASDAQ:VALV) traded as low as $.75 during today’s trading session and closed down at $.99 for a loss of 23.05% from yesterday’s close… VALV shares have traded as high as $6.09 over the past 52 weeks, which is 83.74% off that high at last traded stock price.

Shengkai Innovations is primarily engaged in the design, manufacture and sale of ceramic valves, high-tech ceramic materials and the provision of technical consultation and related services. The Company’s industrial valve products are used by companies in the electric power, petrochemical and chemical, metallurgy and other industries as high-performance, more durable alternatives to traditional metal valves.

Clearwire Corporation (NASDAQ:CLWR) traded as high as $2.11 during today’s trading session and closed up at $2.08 for a gain of 2.75% from yesterday’s close… CLWR shares have traded as high as $6.11 over the past 52 weeks, which is 65.95% off that high at last traded stock price.

Clearwire Corporation, through its operating subsidiaries, is a leading provider of wireless broadband services. Clearwire’s 4G network currently provides coverage in areas of the U.S. where more than 130 million people live. Clearwire’s open all-IP network, combined with significant spectrum holdings, provides an unprecedented combination of speed and mobility to deliver next-generation broadband access. Get my next ALERT 100% FREE

The company markets its 4G service through its own brand called CLEAR®, as well as through its wholesale relationships with companies such as Sprint, Comcast, Time Warner Cable, Locus Telecommunications, Cbeyond, Mitel, Simplexity, United Online and Best Buy. Strategic investors include Intel Capital, Comcast, Sprint, Google, Time Warner Cable, and Bright House Networks.

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) traded as high as $2.07 during today’s trading session and closed up at $2.04 for a gain of 1.49% from yesterday’s close… ASTX shares have traded as high as $3.35 over the past 52 weeks, which is 39.1% off that high at last traded stock price.

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for Injection and receives significant royalties on global sales.

Star Scientific, Inc. (NASDAQ:CIGX) traded as high as $3.38 during today’s trading session and closed up at $3.35 for a gain of .6% from yesterday’s close… CIGX shares have traded as high as $5.35 over the past 52 weeks, which is 37.38% off that high at last traded stock price.

Star Scientific is a technology-oriented company with a mission to reduce the harm associated with tobacco at every level. It is engaged in the development of dissolvable smokeless tobacco products that deliver fewer carcinogenic toxins, principally through the utilization of the innovative StarCured® tobacco curing technology. Its subsidiary, Rock Creek Pharmaceuticals, Inc., is involved in the development of nutraceuticals as well as products to address neurological and mood disorders.

More Posts by this author

Post Written By: Oliver Crowne

Oliver Crowne is the main editor for http://www.StockPreacher.com


Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...